FIRST REGULAR SESSION
HOUSE COMMITTEE SUBSTITUTE FOR
HOUSE BILL NO. 279
91ST GENERAL ASSEMBLY
Reported from the Committee on Children, Families and Health, April 18, 2001, with recommendation that the House Committee Substitute for House Bill No. 279 Do Pass.
TED WEDEL, Chief Clerk
To amend chapter 191, RSMo, by adding thereto one new section relating to supplemental newborn screening.
Section A. Chapter 191, RSMo, is amended by adding thereto one new section, to be known as section 191.332, to read as follows:
191.332. 1. By January 1, 2002, the department of health shall, subject to appropriations, expand the newborn screening requirements in section 191.331 to include potentially treatable or manageable disorders, including cystic fibrosis, galactosemia, biotinidase deficiency, congenital adrenal hyperplasia, maple syrup urine disease (MSUD) and other amino acid disorders, glucose-6-phosphate degydrogenase deficiency (G-6-PD), MCAD and other fatty acid oxidation disorders, methylmalonic acidemia, propionic acidemia, isovaleric acidemia and glutaric acidemia Type I.
2. The department of health may promulgate rules to implement the provisions of this section. No rule or portion
of a rule promulgated pursuant to the authority of this section shall become effective unless it has been promulgated
pursuant to chapter 536, RSMo.